Ewan R. Cameron

The University of Western Australia — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index3.2kcitations88works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(15), Cancer-related Molecular Pathways(12), Acute Myeloid Leukemia Research(11), Renal cell carcinoma treatment(9), Sphingolipid Metabolism and Signaling(8)

Publications88 total

A Simple Decision Tree Model for Detection of Movement Behaviors in Non-Ambulatory Children with Cerebral Palsy
2026Open Access
Abstract 4358298: Atrial Hypertrophy, Fibrosis and Compliance Loss in a Mouse Model of Heart Failure with Preserved Ejection Fraction
Circulation·2025
Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling study
Vaccine·2025· 2 citedOpen Access
<i>Runx1</i> and <i>Runx2</i> act in concert to suppress <i>Wnt/β-catenin</i> -driven mammary tumourigenesis
2025Open Access
Optimized protocols for commonly-used murine models of heart failure with preserved ejection fraction
2025Open Access
Ribonucleicacid interference or small molecule inhibition of<i>Runx</i>1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction
Cardiovascular Research·2023· 12 citedOpen Access
Supplementary Data 1 from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Data from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Data 1 from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Data from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Data from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Table 1 from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Data from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Table 1 from RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome
2023Open Access
Supplementary Figure 1 Legend from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
Supplementary Figure 1 from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
Supplementary Figure 1 Legend from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
Supplementary Figure 1 from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
Data from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
Data from Runx Regulation of Sphingolipid Metabolism and Survival Signaling
2023Open Access
page 1 of 5Next →

Frequent Co-authors

James C. Neil(34), Karen Blyth(30), Anna Kilbey(14), Margaret Bell(13), Anne Terry(12), Nancy MacKay(11), Alma Jenkins(10), Monica Stewart(9), François Vaillant(8), David Onions(6), Linda Hanlon(6), M. Stewart(5), Astrid Terry(5), Euan W. Baxter(5), Laura McDonald(5), Sandy Wotton(5), Gillian Borland(5), Colin Nixon(4), Nicola Ferrari(4), Joanna S. Morris(4)